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Abstract — Aims: The present study examined the association between pre-treatment drinking and smoking parameters and plasma
testosterone levels before and after alcohol withdrawal. Methods: A total of 51 alcohol-dependent men and 43 age-matched healthy
men were investigated. In alcoholics, free testosterone in plasma was measured on the day of admission, after detoxification and after
6 weeks of sobriety. Results: While the testosterone level of alcoholic men did not differ from healthy controls at the onset of
withdrawal, it was significantly higher for the alcoholics after 6 weeks of sobriety than for the healthy controls. Higher alcohol
consumption and higher tobacco use before detoxification led to higher levels of testosterone concentration before and after withdrawal.
Conclusions: The effect of alcohol and tobacco is cumulative, with higher levels of alcohol and tobacco consumption being associated
with higher levels of testosterone before and after alcohol withdrawal.
INTRODUCTION
Alcohol intake affects the activity of the hypothalamic–
pituitary–adrenal (HPA) axis (Heinz et al., 1995, Walter
et al., 2006) and the hypothalamo–pituitary–gonadal (HPG)
axis (Adler, 1992, Schiavi et al., 1995). Though the underlying
mechanisms have not been completely identified, animal and
laboratory studies indicate that alcohol suppresses the activity
of the HPG axis by inhibiting the secretion of hypothalamic-
gonadotropin-releasing hormone (GnRH) and/or pituitary
luteinizing hormone (LH) (Hiney and Dees, 1991, Uddin
et al., 1994). Additionally, alcohol exerts its harmful effect
directly on the testes by reducing the testicular biosynthesis
of testosterone (Va¨lima¨ki et al., 1990, Orpana et al., 1990,
Adams et al., 1997).
It was found that nicotine (the main bioactive biochemical
substance in tobacco) inhibited steroidogenesis in mouse
Leydig cells (Patterson et al., 1990). The chronic treatment
with alcohol and nicotine has been reported to cause decrease
in fertilization ability in male animals (Dhawan and Sharma,
2002). Furthermore, animal studies indicate that not only the
direct effects of nicotine on the sex steroids synthesis but
also the indirect effect of an increased corticosteroid secretion
plays a central role in the effect of drug on testicular steroid
synthesis in the male rat fetus (Sarasin et al., 2003).
In naturalistic studies, chronic alcohol intake reduces
plasma testosterone levels in men (Castilla-Garcia, 1987).
Interestingly, even without alcohol consumption, plasma tes-
tosterone levels decrease in dependent men after experimental
exposure to the sight and smell of alcohol (Meyer and
Dolinsky, 1990). In non-cirrhotic alcoholic men, testosterone
concentrations increase during withdrawal and return to
normal limits after three weeks of abstinence (Heinz et al.,
1995, Ruusa et al., 1997). During alcohol withdrawal, lower
plasma testosterone levels seem to be associated with more
neurotic symptoms while higher hormone levels are related
to a history of seizures (Ruusa and Bergman, 1996). Though
a causal relationship has not yet been established, there is
some evidence for an association between plasma testosterone
levels and alcohol withdrawal symptoms (Ruusa and
Bergman, 1996).
While there have been several studies investigating the
effects of alcohol, little is known about the influence of
tobacco smoking on sex steroids in men. It was found that
nicotine inhibits pulsatile LH secretion in males, and that
this effect disappears within one week after quitting cigarette
smoking (Funabashi et al., 2005). In healthy men, testosterone
levels were negatively correlated with alcohol intake (Muller
et al., 2003), and mainly positively correlated with cigarette
smoking (Tamimi et al., 2001, Svartberg et al., 2003).
To the best of our knowledge, there has been no study
investigating the combined effects of alcohol and tobacco
smoking on plasma testosterone levels in alcoholics. This
report is the first one to examine the impact of drinking and
smoking in alcohol-dependent men on the course of plasma
testosterone concentrations during withdrawal.
METHODS
All data were collected as part of the Wu¨rzburg Addiction-
Research Association Study. The Ethics Committee of the
University of Wu¨rzburg and the Institutional Review Board
of the Department of Psychiatry vetted the study protocol
and gave approval for the present study. Written informed
consent was obtained from each participant before inclusion.
Sample and setting
The sample consisted of 51 male inpatients on the basis
of consecutive admissions to the Alcohol Dependence Treat-
ment Unit of the Psychiatric University Hospital Wuerzburg
(Germany). Eligible for participation were all patients
with (i) current history of alcohol dependence according to
ICD-10 criteria, (ii) verified maintenance of abstinence during
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their stay in the hospital, and (iii) urine toxicology screens
negative for benzodiazepines, cannabinoids, barbiturates,
opiates, cocaine, and amphetamines. Criteria for exclusion
included: (i) evidence of severe medical or neurological
conditions (e.g. cerebral, renal, thyroid, or cardiac disease),
(ii) history of cirrhosis or laboratory evidence of significant
hepatocellular injury, (iii) current substance use disorders
other than tobacco, (iv) current mental or psychiatric condi-
tions or diseases that required psychoactive medication or
inpatient treatment, (v) diagnosis of antisocial personality
disorder, and (vi) history of psychosis. The inclusion and
exclusion criteria were established according to ICD-10 crite-
ria using a German version of the Semi-Structured Assessment
for the Genetics of Alcoholism (SSAGA; Bucholz et al.,
1994). The severity of alcohol withdrawal was investigated
with the Withdrawal Syndrome Scale (WSA; Bech et al.,
1989).
Blood samples for measuring free testosterone in plasma
were always drawn under standardized conditions at 8.30 in
the morning: on the day of admission to the clinic (Day 1),
after successful completion of detoxification (Day 10), and
6 weeks later (Day 40) before discharge from the clinic.
For detoxification, only clomethiazole had been used if
needed. No other medication, e.g. naltrexone, was adminis-
tered. Abstinence was verified by regular alcohol-breath tests.
Control subjects
The 43 members of the control group were recruited as
age-matched, healthy men. Their mean age was 44.6 years
(SD = 12.3). They provided data in a semi-structured psychi-
atric interview, to verify that none of them had any past or
current history of alcoholism, drug dependency, or other
psychiatric disorder or somatic disease. They were all in
good health and were not taking any medication. Blood
samples were taken once at 8.30 a.m. under standardized
conditions.
Testosterone analysis
Blood samples were drawn into chilled tubes prepared with
ethylenediamine tetraacetic acid and aprotinine, immediately
spun at 4C, and the plasma stored at –80C. Plasma concen-
trations of free testosterone were determined using a commer-
cially available radioimmunoassay (DSL-4900 ACTIVETM
Free Testosterone RIA-kit, DSL Deutschland GmbH,
Sinsheim, Germany). The detection limit was 0.18 pg/ml.
Statistical analysis
In order to generate subgroups for the severity of drinking and
smoking, two median splits were calculated. Alcohol and
tobacco use is characterized by the quantity of drinking
(number of standard drinks) and smoking (number of cigar-
ettes) during the last three months prior to admission. The
median splits of quantity result in four severity states of
alcohol and cigarette consumption: low alcohol–low tobacco,
low alcohol–high tobacco, high alcohol–low tobacco, high
alcohol–high tobacco.
All statistical analyses were performed with SPSS/12.0 for
Windows. The parametric methods used were: t-test for
independent samples for group comparisons. ANOVAs with
repeated measures (Day 1, 10, and 40) and up to three group
factors (alcohol consumption, cigarette smoking, withdrawal
score) were used to detect the testosterone course and
the influences on it. Pearson product momentum correlations
(controlled for age and weight) were calculated to evaluate
the associations between testosterone concentrations and
pre-treatment alcohol and tobacco use. A probability of
P < 0.05 was defined as the level of significance.
RESULTS
Table 1 summarizes the demographic and social characteris-
tics of the alcohol-dependent men. Pre-treatment alcohol use
and tobacco use parameters as displayed in Table 2 indicate
that the sample exhibited long-lasting and severe alcohol
misuse.
As shown in Fig. 1, testosterone plasma levels of alcoholics
on Day 1 and 10 did not differ from those of healthy controls.
However, there was a significant increase in the testos-
terone plasma concentration until Day 40 in alcoholic men
(t = –3.15, df = 50, P < 0.001).
The concentrations of testosterone on Day 1, 10, and 40 cor-
related significantly with each other (P < 0.001). Two signifi-
cant correlations between pre-treatment alcohol parameters
and testosterone were found: between total number of drinks
Table 1. Demographic and social data of the alcoholics
Demographic and social characteristics (n = 51)
Age (years)
Mean 42.8
SD 10.2
Range 22–68
Marital status; n (%)
Married 24 (47)
Single 08 (16)
Divorced/separated 19 (37)
Living situation; n (%)
Living alone 17 (33)
Living with a friend or relative 12 (24)
Living with the spouse 22 (43)
Highest grade in school; n (%)
Without graduation 01 (02)
Elementary school 35 (69)
Junior high school 11 (21)
High school 01 (02)
University 03 (06)
Occupational status; n (%)
Employed 33 (65)
Unemployed 17 (33)
Student 01 (02)
Table 2. Pre-treatment drinking and smoking characteristics of the
alcoholics
Drinking and smoking
characteristics (n = 51) Mean SD
Age of alcoholism onset (ICD-10) (years) 29.4 10.7
Duration of alcohol dependence (years) 12.0 8.7
Alcohol consumption during the 3 months prior to admission
Drinking days/month 28.2 5.0
Total number of drinks 2039.6 1149.3
Nicotine use during 3 months prior to admission
Smoking days/month 24.1 11.6
Total number of cigarettes 1768.9 1323.9
Drinks = standard drinks = 10 g ethanol
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and testosterone on Day 1 (r = 0.37, P < 0.01) as well
as between drinking days per months before admission
and testosterone on Day 1 (r = 0.34, P < 0.05). There were
also significant positive correlations between smoking vari-
ables and testosterone concentrations on Day 1 (r = 0.29,
P < 0.05), and between total number of cigarettes and testo-
sterone concentrations on Day 10 (r = 0.31, P < 0.05).
The alcoholics with lower alcohol consumption (n = 23,
45%) had fewer than 1800 standard drinks. The higher alcohol
consumption group (n = 28, 51%) had drunk between 1800
and 5400 standard drinks over the preceding 3 months. Those
alcoholics, with a low cigarette consumption (n = 20, 39%),
smoked fewer than 1800 cigarettes, whereas the high cigarette
consumption group (n = 31, 61%) had smoked a total of
1800–4500 cigarettes during the 3 months preceding the
clinical treatment.
For all four groups (low alcohol-low tobacco, low alcohol-
high tobacco, high alcohol-low tobacco, high alcohol-high
tobacco), there was a significant increase in testosterone over
the 40 days following the withdrawal (F = 19.35, P = 0.0001;
Fig. 2). This increase ran more or less parallel for all groups.
However, as shown in Fig. 2, the four groups differed signifi-
cantly in their testosterone level: the lower the consumption
of alcohol and/or cigarettes had been, the lower were the
measured free testosterone concentrations during and after
the withdrawal period. The severity of the withdrawal
symptoms had no effect, neither on the level of testosterone
nor on its course over the 40 days after withdrawal.
DISCUSSION
To our knowledge, this is the first study investigating the
course of plasma testosterone levels in alcohol dependent
men over such a long period. Additionally, there has been no
study yet investigating the combined effects of alcohol and
smoking on this hormone in alcoholics.
First, our results confirm the findings of Gumus et al.
(1998), who reported an increase in testosterone levels after
alcohol cessation. However, we did not observe recovery
during clinical withdrawal, but only during the following 40
days of abstinence. This indicates that, even in heavy drinking
alcoholics, delayed but significant recovery in testosterone
secretion is possible, as long as there is no severe liver
dysfunction.
Second, we found a positive and significant association
between tobacco smoking and testosterone levels at Day 1
and at Day 10. This is in accordance with the results from a
population-based study reported by Svartberg et al. (2003).
Nevertheless, our study is the first to confirm this relationship
in alcoholics.
11.3
14.3
17.4
13.4
11.6
14.3
11.7
13.9
11.2
12.1
13.3
10.9
7.8
6
8
10
12
14
16
18
Detoxification:
Day 1 
 Day 10 Day 40
Healthy controls
(n=43)
High alcohol & High
tobacco use (n=18)
High alcohol & Low
tobacco use (n=10)
Low alcohol & High
tobacco use (n=13)
Low alcohol & Low
tobacco use (n=10)
ng/dl
***=p<0.001
*=p<0.05
***
***
*
Time-effect p<0.001
Group-effect p<0.001
Fig. 2. Free testosterone in plasma on Day 1, 10, and 40 after detoxification in subgroups of alcoholics with high and low pre-treatment alcohol use
and tobacco use.
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Fig. 1. Free testosterone in plasma on Day 1, 10, and 40 after detoxification in
alcoholics and healthy control group.
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Third, our results do not support the findings reported
by Ruusa and Bergman (1996). While they found that male
alcoholics with low levels of testosterone developed more
symptoms during withdrawal, we could not confirm such an
association. In our sample, plasma testosterone levels
measured immediately before detoxification did not affect
the severity of alcohol withdrawal. However, we used a
pecific withdrawal syndrome scale (WSA), while Ruusa and
Bergman (1996) employed a comprehensive psychopathologi-
cal rating scale (CPRS). Additionally, while they determined
testosterone levels after a mean period of sobriety of
2.5 days, our hormone levels were always measured at Day
1 of treatment. Therefore, methodological diversities might
explain, at least in part—the difference.
Finally, the main goal of this investigation was to analyse
the combined effects of alcohol and smoking. For this reason,
we subdivided our alcohol-dependent participants according
to their (high or low) level of consumption, thus creating
four subgroups: low alcohol–low tobacco (Group 1),
low alcohol–high tobacco (Group 2), high alcohol–low
tobacco (Group 3), and high alcohol–high tobacco (Group
4). As expected, we found higher testosterone levels in those
with high tobacco consumption (Groups 2 and 4), which is in
accordance with the literature reported. However, highest
testosterone levels were observed in the subgroup of those
with both high alcohol and high tobacco consumption (Group
4). Compared with its counter-group with low alcohol and low
tobacco consumption (Group 1), the difference in testosterone
levels was statistically significant at all three time-points.
Since there is no precedent in the literature, we can only
speculate about this unexpected phenomenon. We hypothesize
that in our sample the rebound effect of testosterone recovery
was highest in those who had stressed their testosterone
system most, that is, in the subgroup with highest alcohol
consumption before detoxification. Whatever the explanation
of this phenomenon, our results demonstrate that smoking
matters to testosterone levels in alcoholics. Therefore,
in future studies on this topic, tobacco smoking should be
considered as an important variable.
The results presented must be interpreted from the
perspective of the methodologies used. One important caveat
is the fact that there were only 10–18 men in the subgroups
analysed. Hence, additional studies will be necessary before
more definitive conclusions can be drawn.
We also measured free testosterone (not total testosterone)
and sex hormone binding globulin (SHBG), which means
that our perspective of testosterone is incomplete. However,
Vermeulen et al. (1999) reported that free (i.e. bioavailable)
testosterone reflects the clinical situation more precisely than
the total hormone level or SHBG.
We did not control for other potentially confounding
variables such as body-mass index (BMI), coffee consump-
tion, or physical activity. Although coffee consumption and
physical activity were not associated with free testosterone
in a population based sample (Svartberg et al., 2003) this
might not necessarily apply to smoking alcoholics. Unfortu-
nately neither the number of smokers nor the amount of
tobacco used by the healthy controls was assessed.
This study sought to shed light on the complex relationship
between alcohol/tobacco consumption and plasma testoster-
one levels in alcohol dependent men. The results support the
hypothesis that, in heavily smoking and drinking men, there
is a relationship between higher levels of testosterone and
higher levels of alcohol and tobacco consumption.
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